Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
March 12, 2021 05:03 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The Global Precision Medicine Market is estimated to be USD 53.5 Bn in 2020 and is expected to reach USD 92.2 Bn by 2025 growing at a CAGR of 11.5%.
The factors such as patient s involvement in personal healthcare, development of technologies such as sequencing technologies, increasing genetic diseases, the growing demand for targeted therapies, and integration of big data healthcare companies with pharma & biotech companies are driving the market growth. The increasing population and rising cancer cases in developing countries in the APAC region like India and China are the major factors propelling the growth of the precision medicine market. The current soaring prices of drug discovery along with the increasi
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Portable Medical Devices Market is estimated to be USD 34.6 Bn in 2020 and is expected to reach USD 56.2 Bn by 2025, growing at a CAGR of 10.2%.
The growing incidences of chronic diseases coupled with the rise of the preventive healthcare system are expected to impact the market for portable medical devices in the coming years. The increasing geriatric population is also an important driver for the wireless portable medical devices market, as the elderly people are more prone to illness and often seek immediate diagnosis and monitoring. With increasing government support to healthcare setups in rural areas, the growth of advanced medical devices has surged.
Technology Advancements such as Biomaker and New Gene Therapy for the Treatment
Segments Covered
Based on Drug Class, the pulmonary arterial hypertension (PAH) market has been segmented into Soluble Guanylate Cyclase (SGC) stimulators, prostacyclin and prostacyclin analogs, phosphodiesterase 5 (PDE-5), and Endothelin Receptor Antagonists (ERA). ERA And Prostacyclin And Prostacyclin Analogs for treating PAH have the largest market share owing to the significant increase in the sales of this drug for the treatment of pulmonary arterial hypertension.
Based on Distribution Mode, Online Pharmacies is expected to grow at the highest CAGR during the forecast period. An increase in preferences for e-commerce platforms and also due to the benefits provided by the online pharmacies like discounts & home delivery are fueling the growth of the market.